Gene therapy (introducing genetic material into living cells to fix, replace, enhance, or block a faulty gene) is rapidly ...

The Southeast Asia molecular diagnostics market is set to grow from USD 528.3 million in 2024 to USD 891.9 million by 2031, at a 7.8% CAGR. Key drivers include a rising elderly population, increased ...

Mass photometry enables rapid, purification-free quantification of rAAV vectors, offering a faster solution for gene therapy manufacturing.

Overall survival (OS) in BRCA -mutated breast cancer improved significantly with the addition of olaparib (Lynparza) to ...

NewBiologix, a next-generation biotechnology company pioneering the future of recombinant adeno-associated virus (rAAV) production through a unique DNA-based platform built on stable cell line ...

PCR is a strong laboratory technique that amplifies nucleic acid materials for molecular biology applications like sequencing and gene expression profiling. PCR purification, also known as PCR ...

Innovation of the Year for a product or service The rise of gene therapy has placed adeno-associated virus (AAV) vectors at ...

FMS-like tyrosine kinase 3 (FLT3) mutations represent some of the most pivotal genetic alterations in acute myeloid leukemia (AML), influencing ...

A multi-institutional collaboration of synthetic biology research centers in China has developed a genetically engineered ...

A study published in ACS Nano presents a novel biosensor for the isothermal, highly sensitive detection of bladder cancer ...

NewBiologix has given a non-exclusive technology licence to Recipharm Advanced Bio to provide pharma companies access to ...

New research has identified specific blood-based biomarkers that can predict the failure of prostate cancer treatment in both ...